13F Holdings
中文EN

Kalehua Capital Management LLC

DALLAS TX · SEC CIK 0002106181

2026Q22026Q1 9 earlier quarters 🔒
$313.49M2026Q2 reported value
26Positions
70.1%Top 10 weight · largest 11.4%
8 / 7New / sold out
Reported value over time$313.49M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

MANE 11.4%
XFOR 11.1%
BOXX 8.4%
CMPS 7.4%
SRZN 6.4%
ACRS 6.2%
SION 5.5%
IKT 4.9%
PHVS 4.4%
KPTI 4.3%

2026Q2 top buys estimated at quarter-end value

KPTI New+$13.40M
IFRX New+$12.98M
Cyclerion Therap New+$11.20M
MANE Added+$5.26M
KRRO Added+$3.90M

2026Q2 top sells estimated at quarter-end value

RLAY Sold out-$17.94M
QURE Reduced-$15.84M
BOXX Reduced-$12.94M
ORKA Sold out-$11.63M
PepGen Inc Sold out-$3.06M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
MANE Veradermics Inc $35.82M11.43%291,390 42,81617.2% $5.26M Added
XFOR X4 Pharmaceuticals Inc $34.77M11.09%7,445,680 00.0% — Unchanged
BOXX EA SERIES TRUST $26.48M8.45%226,188 -110,512-32.8% -$12.94M Reduced
CMPS Compass Pathways Plc $23.20M7.40%1,639,384 00.0% — Unchanged
SRZN Surrozen Inc $19.99M6.38%770,356 00.0% — Unchanged
ACRS Aclaris Therapeutics Inc $19.39M6.18%3,664,730 494,80915.6% $2.62M Added
SION Sionna Therapeutics Inc $17.34M5.53%394,144 00.0% — Unchanged
IKT Inhibikase Therapeutics Inc $15.52M4.95%7,643,780 1,149,28217.7% $2.33M Added
PHVS Pharvaris NV $13.75M4.39%397,544 00.0% — Unchanged
KPTI Karyopharm Therapeutics Inc $13.40M4.27%1,371,288 1,371,288— $13.40M New
SEPN Septerna Inc $13.03M4.16%389,088 00.0% — Unchanged
IFRX Inflarx Nv $12.98M4.14%5,795,538 5,795,538— $12.98M New
— Cyclerion Therapeutics Inc $11.20M3.57%3,302,700 3,302,700— $11.20M New
QURE Uniqure Nv $7.31M2.33%158,814 -343,997-68.4% -$15.84M Reduced
— LeonaBio Inc $7.24M2.31%787,402 00.0% — Unchanged
DMRA Damora Therapeutics Inc $7.23M2.31%278,000 00.0% — Unchanged
MLTX MoonLake Immunotherapeutics $6.84M2.18%351,468 00.0% — Unchanged
KRRO Korro Bio Inc $5.34M1.70%405,040 295,664270.3% $3.90M Added
TYRA Tyra Biosciences Inc $4.76M1.52%148,930 00.0% — Unchanged
NVCT Nuvectis Pharma Inc $3.68M1.17%200,000 200,000— $3.68M New
— Gossamer Bio Inc $3.67M1.17%22,298,726 4,590,59325.9% $755,612 Added
— Milestone Pharmaceuticals Inc $3.40M1.09%2,538,474 2,538,474— $3.40M New
ANL Adlai Nortye $2.60M0.83%226,415 226,415— $2.60M New
— Atyr Pharma Inc $2.13M0.68%3,576,334 3,576,334— $2.13M New
— Instil Bio Inc $1.53M0.49%199,200 -123,679-38.3% -$951,092 Reduced
— Tscan Therapeutics Inc $891,6480.28%909,752 909,752— $891,648 New
RLAY Relay Therapeutics Inc $00.00%0 -1,802,914-100.0% -$17.94M Sold out
ORKA Oruka Therapeutics Inc $00.00%0 -237,048-100.0% -$11.63M Sold out
— PepGen Inc $00.00%0 -1,729,961-100.0% -$3.06M Sold out
— Tenaya Therapeutics Inc $00.00%0 -4,000,000-100.0% -$2.77M Sold out
— Kalaris Therapeutics Inc $00.00%0 -271,170-100.0% -$1.56M Sold out
— DiaMedica Therapeutics Inc $00.00%0 -124,976-100.0% -$846,088 Sold out
— LONGEVERON INC $00.00%0 -347,539-100.0% -$361,441 Sold out